Research Article
Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus
Table 2
Results of laboratory tests before and 1 week after procedure.
| ||||||||||||||||||||||||||||||||||||||||||||||||
ALB = albumin; ALT = alanine transaminase; AST = aspartate transaminase; CR = creatinine; CTCAE = Common Toxicity Criteria for Adverse Events; PLT = platelets; PT = prothrombin time; TB = total bilirubin. Data expressed as mean ± SD. |